These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31340155)

  • 21. SL-Miner: a web server for mining evidence and prioritization of cancer-specific synthetic lethality.
    Liu X; Hu J; Zheng J
    Bioinformatics; 2024 Feb; 40(2):. PubMed ID: 38244572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic lethality as an engine for cancer drug target discovery.
    Huang A; Garraway LA; Ashworth A; Weber B
    Nat Rev Drug Discov; 2020 Jan; 19(1):23-38. PubMed ID: 31712683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The concept of synthetic lethality in the context of anticancer therapy.
    Kaelin WG
    Nat Rev Cancer; 2005 Sep; 5(9):689-98. PubMed ID: 16110319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SynLethDB 2.0: a web-based knowledge graph database on synthetic lethality for novel anticancer drug discovery.
    Wang J; Wu M; Huang X; Wang L; Zhang S; Liu H; Zheng J
    Database (Oxford); 2022 May; 2022():. PubMed ID: 35562840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive prediction of robust synthetic lethality between paralog pairs in cancer cell lines.
    De Kegel B; Quinn N; Thompson NA; Adams DJ; Ryan CJ
    Cell Syst; 2021 Dec; 12(12):1144-1159.e6. PubMed ID: 34529928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STAG Mutations in Cancer.
    Romero-Pérez L; Surdez D; Brunet E; Delattre O; Grünewald TGP
    Trends Cancer; 2019 Aug; 5(8):506-520. PubMed ID: 31421907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic analysis of cancer-specific synthetic lethal interactions provides insight into personalized anticancer therapy.
    Guo L; Dou Y; Xiang Y; Luo L; Xu X; Wang Q; Zhang Y; Liang T
    FEBS J; 2023 Mar; 290(6):1531-1548. PubMed ID: 36181326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human synthetic lethal inference as potential anti-cancer target gene detection.
    Conde-Pueyo N; Munteanu A; Solé RV; Rodríguez-Caso C
    BMC Syst Biol; 2009 Dec; 3():116. PubMed ID: 20015360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthetic lethal vulnerabilities of cancer.
    Fece de la Cruz F; Gapp BV; Nijman SM
    Annu Rev Pharmacol Toxicol; 2015; 55():513-31. PubMed ID: 25340932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic Lethality: From Research to Precision Cancer Nanomedicine.
    Gupta A; Ahmad A; Dar AI; Khan R
    Curr Cancer Drug Targets; 2018; 18(4):337-346. PubMed ID: 28669337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of Synthetic Lethality by Natural Compounds Targeting Cancer Signaling.
    Farrand L; Byun S
    Curr Pharm Des; 2017 Nov; 23(29):4311-4320. PubMed ID: 28699516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Molecular 'Myc-anisms' Behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics.
    McAnulty J; DiFeo A
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322239
    [No Abstract]   [Full Text] [Related]  

  • 33. GDISC: a web portal for integrative analysis of gene-drug interaction for survival in cancer.
    Spainhour JCG; Lim J; Qiu P
    Bioinformatics; 2017 May; 33(9):1426-1428. PubMed ID: 28453687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthetic lethality in large-scale integrated metabolic and regulatory network models of human cells.
    Barrena N; Valcárcel LV; Olaverri-Mendizabal D; Apaolaza I; Planes FJ
    NPJ Syst Biol Appl; 2023 Jul; 9(1):32. PubMed ID: 37454223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting Synthetic Lethality in Human Cancers via Multi-Graph Ensemble Neural Network.
    Lai M; Chen G; Yang H; Yang J; Jiang Z; Wu M; Zheng J
    Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():1731-1734. PubMed ID: 34891621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overcoming selection bias in synthetic lethality prediction.
    Seale C; Tepeli Y; Gonçalves JP
    Bioinformatics; 2022 Sep; 38(18):4360-4368. PubMed ID: 35876858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A network-based approach to integrate nutrient microenvironment in the prediction of synthetic lethality in cancer metabolism.
    Apaolaza I; San José-Enériz E; Valcarcel LV; Agirre X; Prosper F; Planes FJ
    PLoS Comput Biol; 2022 Mar; 18(3):e1009395. PubMed ID: 35286311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DiscoverSL: an R package for multi-omic data driven prediction of synthetic lethality in cancers.
    Das S; Deng X; Camphausen K; Shankavaram U
    Bioinformatics; 2019 Feb; 35(4):701-702. PubMed ID: 30059974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting cancer-specific vulnerability via data-driven detection of synthetic lethality.
    Jerby-Arnon L; Pfetzer N; Waldman YY; McGarry L; James D; Shanks E; Seashore-Ludlow B; Weinstock A; Geiger T; Clemons PA; Gottlieb E; Ruppin E
    Cell; 2014 Aug; 158(5):1199-1209. PubMed ID: 25171417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional genomics identifies specific vulnerabilities in PTEN-deficient breast cancer.
    Tang YC; Ho SC; Tan E; Ng AWT; McPherson JR; Goh GYL; Teh BT; Bard F; Rozen SG
    Breast Cancer Res; 2018 Mar; 20(1):22. PubMed ID: 29566768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.